Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996331 · ClinicalTrials.gov registry record · NA
Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 2,113
- Enrollment target
NCT02996331: Completed NA study, sponsored by Duke University.
NCT02996331 is a NA study that has completed, run by Duke University. The registered enrollment target is 2,113 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02996331, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,113 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether repositioning frequency can be extended for nursing home (NH) residents who are low, moderate, and high risk for pressure ulcer (PrU) development. The investigators will also determine how changes in medical severity interact with changes in risk level and repositioning schedule to predict PrU development. This study will advance knowledge about repositioning frequency and clinically assessed PrU risk-level in relation to medical severity. Outcomes of this research will contribute to future guidelines for more precise preventive nursing practices and refinement of PrU prevention guidelines.
Primary Outcome
Determine differences in the incidence of new PrUs in NH residents at low, moderate, and high risk using VE surfaces and repositioned at 2, 3, or 4 hour frequencies, in nine randomly assigned NHs over a 4-week period. We hypothesize that there will be no significant difference in PrU incidence between the 3 treatment arms in the study using three risk level groups: high risk (Braden Scale Score, 10-12), moderate risk (Braden Scale Score, 13-14), and low risk (Braden Scores \>14). The hypothesis
Interventions
- OTHER 2 hour repositioning
- OTHER 3 hour repositioning
- OTHER 4 hour repositioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,113 participants |
| Start Date | 2017-05-16 |
| Est. Completion | 2019-10-11 |
| Phase | NA |
What the finished NCT02996331 record still lists
NCT02996331 is an interventional study that assigns participants to a tested intervention. Its 2,113 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% higher).
The record links to 0 conditions, and to 3 interventions - of which 2 hour repositioning is the first listed.
NCT02996331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02996331 about?
NCT02996331 is a clinical study titled "Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors". The purpose of this study is to determine whether repositioning frequency can be extended for nursing home (NH) residents who are low, moderate, and high risk for pressure ulcer (PrU) development. The investigators will also determine how changes in medical severity interact with changes in risk lev...
What is the current status of trial NCT02996331?
This trial is currently completed. It is a NA study. The enrollment target is 2,113 participants. The study started on 2017-05-16. Estimated completion is 2019-10-11.
What interventions are being tested in trial NCT02996331?
The interventions under investigation include: 2 hour repositioning (OTHER), 3 hour repositioning (OTHER), 4 hour repositioning (OTHER).
Who is sponsoring clinical trial NCT02996331?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02996331's enrollment target sits among peer trials
2,113 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05916430 · 2,120 participants
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
- NCT05967273 · 2,106 participants · NA
CirrhosisRx CDS System
- NCT05681624 · 2,124 participants · NA
Maternal Oxygen Supplementation for Intrauterine Resuscitation
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI